Drug
Cdx 1140
Cdx 1140: highest development phase Phase 1, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-1140 NCT03329950 | Phase 1 | Melanoma |
Latest
No recent events.
Follow Cdx 1140 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.